tiprankstipranks
Advertisement
Advertisement

AU:OCC Stock Latest News

Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
Company AnnouncementsOrthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
4d ago
OCC
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
PremiumCompany Announcements
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
7d ago
OCC
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
PremiumCompany Announcements
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
9d ago
OCC
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
PremiumCompany Announcements
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
9d ago
OCC
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
PremiumCompany Announcements
Orthocell to Outline March-Quarter Results and Remplir Rollout in Investor Webinar
10d ago
OCC
Orthocell courts investors with biotech presentation as global product rollout advances
PremiumCompany AnnouncementsOrthocell courts investors with biotech presentation as global product rollout advances
24d ago
OCC
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
Premium
Company Announcements
Orthocell reports lapse of 16,567 retention rights, trimming potential equity
1M ago
OCC
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
Premium
Company Announcements
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
1M ago
OCC
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
PremiumCompany Announcements
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
2M ago
OCC
Orthocell director Michael McNulty increases on‑market shareholding
PremiumCompany Announcements
Orthocell director Michael McNulty increases on‑market shareholding
2M ago
OCC
Orthocell Director Increases Shareholding Through On-Market Purchase
PremiumCompany Announcements
Orthocell Director Increases Shareholding Through On-Market Purchase
2M ago
OCC
Orthocell posts record half-year revenue as global expansion gains pace
PremiumCompany Announcements
Orthocell posts record half-year revenue as global expansion gains pace
2M ago
OCC
Orthocell Issues Confidential US Market Update with Standard Legal Disclaimers
PremiumCompany AnnouncementsOrthocell Issues Confidential US Market Update with Standard Legal Disclaimers
3M ago
OCC
Orthocell to Brief Investors on US Rollout of Remplir and Operational Progress
Premium
Company Announcements
Orthocell to Brief Investors on US Rollout of Remplir and Operational Progress
3M ago
OCC
Orthocell Posts Record Revenue as Remplir Global Rollout Accelerates
Premium
Company Announcements
Orthocell Posts Record Revenue as Remplir Global Rollout Accelerates
3M ago
OCC
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
PremiumCompany Announcements
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
3M ago
OCC
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
PremiumCompany Announcements
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
4M ago
OCC
Orthocell CEO Increases Shareholding Through Vesting of Performance Rights
PremiumCompany Announcements
Orthocell CEO Increases Shareholding Through Vesting of Performance Rights
4M ago
OCC
Orthocell Issues New Shares on Exercise of Performance Rights
PremiumCompany Announcements
Orthocell Issues New Shares on Exercise of Performance Rights
4M ago
OCC
Orthocell Seeks ASX Quotation for 217,742 New Ordinary Shares
PremiumCompany AnnouncementsOrthocell Seeks ASX Quotation for 217,742 New Ordinary Shares
4M ago
OCC
Orthocell Reaches Key U.S. Milestone with Remplir™ Nerve Repair Product
Premium
Company Announcements
Orthocell Reaches Key U.S. Milestone with Remplir™ Nerve Repair Product
4M ago
OCC
Orthocell Seeks EU and UK Approval for Nerve Repair Product Remplir™
Premium
Company Announcements
Orthocell Seeks EU and UK Approval for Nerve Repair Product Remplir™
4M ago
OCC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >